Artiva Biotherapeutics (ARTV) Institutional Ownership $2.00 -0.16 (-7.41%) Closing price 05/21/2025 04:00 PM EasternExtended Trading$2.06 +0.06 (+3.25%) As of 05/21/2025 07:21 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsTrendsBuy This Stock Institutional Ownership Changes (13F Filings) for Artiva Biotherapeutics (NASDAQ:ARTV)Number ofInstitutional Buyers(last 12 months)19TotalInstitutional Inflows(last 12 months)$179.75MNumber ofInstitutional Sellers(last 12 months)3TotalInstitutional Outflows(last 12 months)$1.05M Get ARTV Insider Trade Alerts Want to know when executives and insiders are buying or selling Artiva Biotherapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data ARTV Institutional Buying and Selling by Quarter Artiva Biotherapeutics Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails5/15/2025 venBio Partners LLC1,198,975$3.60M2.9%-21.1%4.921% 5/12/2025 Nuveen LLC47,892$144K0.0%N/A0.197% 5/9/2025 Charles Schwab Investment Management Inc.54,881$165K0.0%+26.1%0.225% 2/17/2025 Deutsche Bank AG21,423$216K0.0%N/A0.088% 2/17/2025 Bank of America Corp DE10,817$109K0.0%-39.3%0.045% 2/17/2025 BNP Paribas Financial Markets9,879$100K0.0%+262.1%0.041% 2/14/2025 Northern Trust Corp117,112$1.18M0.0%+3.8%0.482% 2/13/2025 Barclays PLC24,161$244K0.0%+23.2%0.099% 2/13/2025 Wells Fargo & Company MN8,616$87K0.0%+64.0%0.035% 2/12/2025 Geode Capital Management LLC315,758$3.18M0.0%+2.2%1.300% Get the Latest News and Ratings for ARTV and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Artiva Biotherapeutics and its competitors with MarketBeat's FREE daily newsletter. 2/12/2025 Norges Bank30,000$302K0.0%N/A0.124% 2/12/2025 JPMorgan Chase & Co.37,619$379K0.0%+250.7%0.155% 2/6/2025 Charles Schwab Investment Management Inc.43,526$439K0.0%+8.0%0.179% 1/30/2025 Rhumbline Advisers12,879$130K0.0%-13.1%0.053% 1/24/2025 China Universal Asset Management Co. Ltd.5,150$52K0.0%N/A0.021% 12/26/2024 JPMorgan Chase & Co.10,726$166K0.0%N/A0.044% 11/27/2024 Franklin Resources Inc.520,301$7.44M0.0%N/A2.142% 11/19/2024 Barclays PLC19,616$304K0.0%N/A0.081% 11/16/2024 Geode Capital Management LLC308,930$4.77M0.0%N/A1.272% 11/15/2024 Barclays PLC19,616$304K0.0%N/A0.081% 11/15/2024 Wellington Management Group LLP194,108$2.91M0.0%N/A0.799% 11/15/2024 State Street Corp86,559$1.34M0.0%N/A0.356% 11/15/2024 Samsara BioCapital LLC291,666$4.51M0.9%N/A1.201% 11/15/2024 RA Capital Management L.P.9,853,302$152.23M1.8%N/A40.565% 11/15/2024 RTW Investments LP148,844$2.30M0.0%N/A0.613% 11/14/2024 Acuta Capital Partners LLC44,000$680K0.6%N/A0.181% 11/14/2024 MetLife Investment Management LLC8,733$135K0.0%N/A0.036% 11/13/2024 BNP Paribas Financial Markets2,728$42K0.0%N/A0.011% 11/12/2024 Charles Schwab Investment Management Inc.40,293$623K0.0%N/A0.166% (Data available from 1/1/2016 forward) ARTV Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of ARTV shares? During the previous two years, 22 institutional investors and hedge funds held shares of Artiva Biotherapeutics. The most heavily invested institutionals were RA Capital Management L.P. ($152.23M), Franklin Resources Inc. ($7.44M), Samsara BioCapital LLC ($4.51M), venBio Partners LLC ($3.60M), Geode Capital Management LLC ($3.18M), Wellington Management Group LLP ($2.91M), and RTW Investments LP ($2.30M).Learn more on ARTV's institutional investors. Which institutional investors have been buying Artiva Biotherapeutics stock? Of the 19 institutional investors that purchased Artiva Biotherapeutics stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: RA Capital Management L.P. ($9.85M), Franklin Resources Inc. ($520.30K), Geode Capital Management LLC ($315.76K), Samsara BioCapital LLC ($291.67K), Wellington Management Group LLP ($194.11K), RTW Investments LP ($148.84K), and State Street Corp ($86.56K). How much institutional buying is happening at Artiva Biotherapeutics? Institutional investors have bought a total of 11,721,588 shares in the last 24 months. This purchase volume represents approximately $179.75M in transactions. Which Artiva Biotherapeutics major shareholders have been selling company stock? The following institutional investors have sold Artiva Biotherapeutics stock in the last 24 months: venBio Partners LLC ($321.00K), Bank of America Corp DE ($7.00K), and Rhumbline Advisers ($1.95K). How much institutional selling is happening at Artiva Biotherapeutics? Institutional investors have sold a total of 329,947 shares in the last 24 months. This volume of shares sold represents approximately $1.05M in transactions. Related Companies KOD Major Shareholders TNXP Major Shareholders CRDF Major Shareholders SOPH Major Shareholders VYGR Major Shareholders YMAB Major Shareholders CRGX Major Shareholders SCPH Major Shareholders NBTX Major Shareholders DMAC Major Shareholders This page (NASDAQ:ARTV) was last updated on 5/22/2025 by MarketBeat.com Staff From Our PartnersJuly 2025 Rule Change to Impact Retirement InvestorsThere's a massive change from a new rule going into effect this July. And it's one the Big Banks are alread...Premier Gold Co | SponsoredA new financial chapter Porter Stansberry says what happened last week could become the defining legacy of his financial publishing ca...Porter & Company | SponsoredThe Secret Map of America, Declassified…Locked inside a Maryland man’s private safe is a map. But not just any map, mind you… This map shows a “...Banyan Hill Publishing | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredElon’s backup plan for AIElon knows the future isn’t about smarter AI — it’s about powering it. And this new technology is quietly b...True Market Insiders | SponsoredExclusive Offer: Target 100% Returns NowBrace yourself–this may come as a shock. It turns out that you may not have to wait decades to turn a small...ProsperityPub | SponsoredPrepare now for May 31 eventPrepare now for May 31 event Circle May 31 on your calendar This man grew up in a trailer in New Mexico. To...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Artiva Biotherapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Artiva Biotherapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy ARTV Stock Free ARTV Stock Alerts